The Cost of Dying, 60 Minutes
In case you missed it.
Comments
One Response to “The Cost of Dying, 60 Minutes”Trackbacks
Check out what others are saying about this post...-
[...] a reasonable discussion about health care; that a provision to remunerate consultations regarding end of life issues somehow turned into “pulling the plug on grandma” and “death panel” sound [...]
Speak Your Mind
Tell us what you're thinking...and oh, if you want a pic to show with your comment, go get a gravatar!
Recent Posts
-
Places Cited
Posts from Health Reform Watch have been cited by media sources throughout the country, including The New York Times, Washington Post, L.A. Times, Kaiser Health News, The Health Care Blog, NPR's Planet Money Blog, Duke Univ. Med. Center News, American Health Line Alerts, BusinessWeek.com, Concurring Opinions, Balkinization, The New England Journal of Medicine, Harvard's Nieman Foundation for Journalism, Las Vegas Sun, Maggie Mahar, Ezra Klein, Tom Geoghegan, and the official homepage of the Office of the Democratic Majority Leader of the House of Representatives, Steny Hoyer.
-
Study Law Abroad
Kaiser- The Commonwealth Fund
- Recommended Core Measures for Evaluating the Patient-Centered Medical Home: Cost, Utilization, and Clinical QualityThis Commonwealth Fund data brief describes how more than 70 researchers came together as part of the Patient-Centered Medical Home Evaluators’ Collaborative to identify a set of standardized measures to assess patient-centered medical homes.
- The World Health Report 2008—Primary Healthcare: How Wide Is the Gap Between Its Agenda and Implementation in 12 High-Income Health Systems?The authors of this Commonwealth Fund-supported study report on how the policy reforms set forth by the World Health Organization in 2008 are being implemented in 12 wealthy health systems.
- Guidelines International Network: Toward International Standards for Clinical Practice GuidelinesThe authors of this Commonwealth Fund-supported study identified some steps that can be taken by the Guidelines International Network to ensure that guideline development processes "are both rigorous and feasible even for modestly funded groups to implement."
- Integrating Immigrants into the U.S. Health SystemThe authors of this Commonwealth Fund-supported study argue that physicians must develop competencies to provide culturally sensitive care to a more diverse patient population.
- State Scorecard on Long-Term Services and Supports: What Distinguishes High- from Low-Ranking States?Last September, the AARP Public Policy Institute, The Commonwealth Fund, and The SCAN Foundation released the first-ever State Scorecard on Long-Term Services and Supports (LTSS). A new set of case studies provides insights into why certain states ranked high, low, or somewhere in between.
- Recommended Core Measures for Evaluating the Patient-Centered Medical Home: Cost, Utilization, and Clinical Quality
- RWJF Health Reform News
- GOP Shies Away from Offering Healthcare Reform AlternativeRepublicans might not offer a comprehensive plan to replace President Obama’s healthcare law if the Supreme Court strikes it down this summer.
- Study: Privately Insured Kids Get More Care in EDEmergency departments are required to treat everyone who comes through the doors, but that doesn’t mean they treat everyone the same way.
- Obesity, a New Kind of SmokeThe war on smoking can help guide the nation’s fight against obesity. Trash food can be the cigarette.
- Have California Schools Cracked the Code on Obesity?When it comes to nutrition policy, we know about a lot of things that don’t work: Soda taxes and proximity to healthy foods, for example, have relatively shaky support in the public health literature.
- Type 2 Diabetes in Kids not Child’s PlayIf ever we needed a wake-up call on the state of American children’s health, consider the growing proliferation of Type 2 diabetes in our youth, as detailed in a study recently published in The New England Journal of Medicine.
- GOP Shies Away from Offering Healthcare Reform Alternative
- ACA Litigation Blog
- NY Times Health Policy
- F.D.A. Panel Backs Easier Home H.I.V. TestAn advisory body recommended that the Food and Drug Administration approve the OraQuick test, which uses a mouth swab to give a result in 20 minutes.
- Romney Medicare Plan Draws Stark Contrast With Obama’sMitt Romney says President Obama has no workable plan to prevent Medicare from going bankrupt, and that he is offering “a dramatic change in perspective and philosophy.”
- News Analysis: Taking Truvada to Prevent H.I.V. Also Comes With RisksTaking Truvada daily can help people in at-risk groups prevent H.I.V. infection, but the consequences of loose adherence go beyond contracting the virus.
- Whooping Cough Epidemic Hits Washington StateEfforts in Washington State to address a resurgent childhood ailment have been hobbled by years of recession-induced budget cuts that have hollowed out public health departments.
- Economic View: Slippery-Slope Logic vs. Health Care Law - Economic ViewThe court debate over the new health care law offers yet another example of worrying about imaginary risks.
- F.D.A. Panel Backs Easier Home H.I.V. Test
- WaPo Health
- President’s Council on Fitness backs Wii, Kinect and other video gamesWe called it “the devil’s machine” in my house, and the Faustian bargain we struck over that first Nintendo 64 would have impressed Lucifer himself. We bought it for my son when he was perhaps 7; it provided countless hours of contentment for him and an equal measure of downtime for Mom and Dad. Read full article >>
- The struggles of D.C. area yoga studiosThe deal with yoga in Washington is getting kind of complicated. If it’s a bargain you’re after, that’s not hard to find, especially with DC Yoga Week starting Sunday. Now in its seventh year, the event is eight days of free and $5 classes at 24 studios across the area. (This year, Maryland and Virginia studios are taking part, too.) And any other wee […]
- Spin/yoga classes find balance of body and mindIt seems as though we are always struggling for balance in our lives. Work or play? Spend or save? Eat that doughnut or save those calories? The same is true for our fitness regimens. Everyone from the Centers for Disease Control and Prevention to your physician wants you to mix cardiovascular workouts with strength training, stretching and balance drills. […]
- Alternative bachelorette parties: trapeze, ballet barre, ropes course and moreThe morning after 25-year-old Nicki Bonebrake’s bachelorette party two weeks ago, she could barely get out of bed. The problem wasn’t that the Gaithersburg resident had stayed out all night with her friends — although she had. It was that her body was still dealing with the fact that she’d spent the previous morning learning the art of flying trapez […]
- 5 so-called health foods you should avoidEating healthy can be harder than you think, thanks to an enterprising food industry that wants us to consume more than we need. That’s because our country’s agricultural system produces twice what most people require, according to the U.S. Department of Agriculture’s Economic Research Service. This encourages creative marketing to unload the excess, […]
- President’s Council on Fitness backs Wii, Kinect and other video games
- Fierce Healthcare
- Piramal bets on pharma's data binging in $635M buyoutSold on the growing need for market data in biopharma, India's Piramal Healthcare has scooped up Decision Resources Group in deal valued at about $635 million, Piramal and DRG revealed Wednesday. The deal comes amid rapid business expansion at Decision Resources, which provides web-based research tools, predictive analytics and other services to drugmak […]
- Cancer drug experts brace for ASCO abstract dump tonight Tonight's the big night for cancer drug watchers. ASCO is releasing a mountain of data on cancer studies, and some of the biggest names in the business will be angling for star billing on some closely watched therapies. Peter Loftus at Dow Jones lists Pfizer ($PFE), GlaxoSmithKline ($GSK) and Johnson & Johnson ($JNJ) among the big names that will b […]
- UPDATED: Upstart Ra sheds stealth status, targets new drug classCambridge, MA-based Ra Pharmaceuticals is stealth no more. Two years after it snagged an initial $10 million in venture cash, Ra has hauled in a second tranche of $8.6 million and picked its disease target: hereditary angioedema, a rare and lethal immune system disorder. And after maintaining strict silence as the biotech was being incubated at Morgenthaler […]
- Achillion burnishes buyout prospects, snags fast track for hep C drugAchillion CEO Michael Kishbauch hasn't been the least bit shy about touting the company's buyout prospects. Quick to boast about the biotech's promising hepatitis C drugs, he's been raising hopes and stirring buyout buzz with every appearance. And today Kishbauch is sporting another feather in his cap: An FDA fast-track designation for a […]
- Elevation boasts 'gold standard' IIb data for COPD therapyFour months ago San Diego-based Elevation Pharmaceuticals unveiled a $30 million venture round as it mapped out plans to complete an ambitious mid-stage program for its COPD treatment. Today the biotech boasted that the therapy--EP-101--had registered positive data in a Phase IIb study, positioning it as a potential new "gold standard" in nebulized […]
- Genentech drug picked for pioneering $100M Alzheimer's trialThe NIH has agreed to help bankroll a pioneering $100 million study of Genentech's experimental Alzheimer's therapy crenezumab. Investigators will test the drug in a region of Colombia where a particular genetic mutation is known to trigger the early onset of Alzheimer's, with an eye to determining if they can stop the memory-wasting ailment b […]
- Payers likely to throw up hurdles to Pfizer's new RA drugYou know that old adage: The one with the gold makes the rules? For the latest exhibit, look no further than Pfizer's ($PFE) anticipated rheumatoid arthritis treatment tofacitinib. After an FDA advisory panel voted in favor of the drug last week, Reimbursement Intelligence surveyed 30 big payers, asking how they'd manage access to the new treatment […]
- First wave of AstraZeneca's CNS R&D group gets the ax AstraZeneca isn't wasting any time in pushing ahead with draconian cuts to its neuroscience work in its big R&D hub south of Stockholm. The first 50 scientists have already been shown the door, according to local news reports, part of the first wave of 400 job cuts as AstraZeneca ($AZN) slashes a total of 1,100 positions at the research complex. […]
- Newron soars on positive PhIII results, $26M pact for Parkinson's drugDespite being left at the M&A altar last fall after a key partnership deal collapsed, Newron says it has successfully completed two late-stage studies of its experimental Parkinson's drug. And the Italian biotech used the opportunity to announce that it has garnered a 20 million euro licensing deal with Zambon for the drug. At the same time, Newron […]
- Buzz: Big Pharma suitors line up for a look at Amylin's booksOne of the cardinal rules involved in deal-making focuses on the need to get as many buyers to the negotiating table as possible. The next big rule: Make sure everyone knows who's interested in bidding. Amylin--while maintaining a strict no comment policy ever since initial reports appeared the Bristol-Myers Squibb ($BMY) had made an offer--has scored o […]
- Piramal bets on pharma's data binging in $635M buyout
- Boston Globe Health Blog
- MIT professor wins prestigious chemistry prizeBy Carolyn Y. Johnson, Globe Staff Robert Langer, a biomedical engineer at MIT best known for his contributions in the fields of tissue engineering and drug delivery, has been named the winner of the 2012 Priestley Medal, a prestigious prize...
- Daily check up: New York Times points to Mass. public opinion on health care mandate as a modelIn an editorial today, the Times says support for the national mandate could follow the recent trend in Mass. and grow
- Brigham and Women's performs face transplant on woman mauled by chimpJonathan Wiggs / Globe Staff Photo Steve Nash, brother of Charla Nash, who received a full face transplant at Brigham and Women's Hospital late last month, appeared at a press conference today with his wife, Kate. Charla Nash did not...
- Poll: Public supports mandatory physical educationIn a survey of 501 Mass. residents, 87 percent said the state should require 30 min. of physical activity each school day
- Immigrant health care back in courtImmigrant advocates had hoped for a quick decision, but the state plans to file a motion that would delay the process
- MIT professor wins prestigious chemistry prize
- LA Times Health Blog
- Breast cancer study reveals 'substantial genetic diversity'A new study of the protein-coding genes in 100 breast cancer tumors revealed vast differences among the cancers and highlights how complicated the disease really is, researchers said Wednesday.
- Healthy food doesn't have to be expensive, USDA insistsHealthy food, we’ve often heard, is pricey food. Fruits and vegetables -- they’re expensive! We can’t afford to eat that way! That’s why we don’t do it!
- Chain restaurants don't meet U.S. nutrition guidelines, study saysPlenty of restaurants have been advertising their efforts to offer healthful choices, and it’s possible to eat carefully just about anywhere. But researchers say nearly all the entrees they reviewed at 245 U.S. chains fail to meet federal guidelines.
- Breast cancer study reveals 'substantial genetic diversity'
- Health Affairs Blog
- Remembering Larry Lewin: A Legacy Of Accomplishment And MentorshipOn April 29, 2012, four days after his 74th birthday, Larry Lewin (pictured below) died from complications of an underlying cancer. The funeral was May 1 and his wife, Marion asked me to speak briefly about his professional life. What follows is adapted from those remarks. It will be obvious that anyone who knew Larry [...]
- Electronic Prescribing: Where We Stand And Lessons For PolicymakersEditor’s note: For more on the adoption of electronic health systems, see these recent Health Affairs articles by Decker and coauthors, DesRoches and coauthors, and Hsiao and coauthors, which were discussed at an April 25 event. Since the American Recovery and Reinvestment Act passed in 2009, healthcare professionals, researchers, analysts and policy m […]
- The Latest Health Wonk ReviewA belated tip of the hat to Hank Stern’s Health Wonk Review at Insure Blog. Hank offers a nice collection of posts, including Diane Meier’s Health Affairs Blog post on Amy Berman’s Narrative Matters essay and overcoming barriers to palliative care. Happy reading!
- Early Lessons From A Shared Risk, Integrated Care Organization Serving A Commercial PopulationBackground: The Centers for Medicare and Medicaid Services’ designation of 32 accountable care organizations (ACOs) across the U.S. to enroll Medicare fee-for-service patients beginning in 2012 makes ACOs an important feature of the national healthcare landscape–at least for publicly insured patients.However in 2007, Blue Shield of California, along wi […]
- When Epidemiology Goes Astray: Valuing Cancer Care In The United States And EuropeIn a recent Health Affairs paper, we documented that the United States has a significant survival advantage over much of Europe when it comes to cancer: 1.8 years for those diagnosed during our study window. Furthermore, we showed over a 17-year period that this gap had widened, not narrowed, and that this widening was more [...]
- Remembering Larry Lewin: A Legacy Of Accomplishment And Mentorship
Center News, Programs & Papers
